MetaCap

electroCore (ECOR) vs Valion Bio (VBIO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

electroCore is the larger company by market cap ($40.8 million vs $1.0 million), about 39.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ECOR-54.53%VBIO-78.05%
+5%-39%-82%
Oct 7, 20261 yearNov 20, 2026
ECOR-54.24%VBIO-77.54%
+4%-39%-81%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ECOR versus VBIO key metrics
MetricECORVBIO
Share price$4.42$0.4806
Market cap$40.78M$1.04M
1-day change-8.87%-10.98%
YTD return-1.45%—
1-year return-6.16%—
5-year return-61.23%—
EPS (TTM)$-1.36$-177.91
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$32.03M—
Revenue growth (YoY)+27.20%—
Net income (latest FY)$-13.97M$-8.88M
Gross margin86.75%—
Operating margin-41.06%—
Net margin-43.60%—
52-week high$12.70$67.50
52-week low$3.90$0.472
Distance from 52-week high-65.20%-99.29%
Analyst consensusnone—
Avg. price target upside+333.71%—
Average volume120.32K1.78M
Shares outstanding9.23M2.16M
Employees8352
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • electroCore is about 39.4 times larger than Valion Bio by market value ($40.78M vs $1.04M).

About electroCore

ECOR stock →

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 83 employees

About Valion Bio

VBIO stock →

Valion Bio, Inc. operates as a late-stage biopharmaceutical company.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 52 employees

ECOR vs VBIO FAQ

Which is bigger, electroCore or Valion Bio?

electroCore (ECOR) is larger, with a market capitalization of $40.78M compared with $1.04M for Valion Bio (VBIO).

Are electroCore and Valion Bio in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons